Author

N. K. Dashzeveg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

H. Liu· 4 shared L. El-Shennawy· 4 shared Y. Jia· 4 shared A. D. Hoffmann· 3 shared Y. Shen· 3 shared C.-F. Tsai· 2 shared D. Fang· 2 shared D. Scholten· 2 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

H. Liu

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Novel antibody language model accelerates IgG screening and design for broad-spectrum antiviral therapy

H. F. Mubarak, W. Tan, A. D. Hoffmann, Y. Sun, J. Wei, L. El-Shennawy, J. R. Squires, N. K. Dashzeveg, B. Simonton, Y. Jia, R. Iyer, Y. Xu, V. Nicolaescu, D. Elli, G. C. Randall, , Y. Shen

This paper introduces an antibody language model (AbLM) to accelerate IgG screening and design for broad-spectrum antiviral therapy, achieving higher precision in predicting variant-resistant antibodies.

bioRxiv · Mar 1, 2024 · PreprintImmunology

Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

E. J. Schuster, N. K. Dashzeveg, Y. Jia, K. Golam, T. Zhang, A. D. Hoffman, Y. Zhang, C. Zheng, E. K. Ramos, R. Taftaf, L. El-Shennawy, D. Scholten, V. Adorno-Cruz, C. Reduzzi, R. Xu, , S. Spahija

This study identifies Plexin-B2 as a driver of homotypic and heterotypic CTC clusters in breast cancer metastasis, with high expression linked to poor prognosis and therapeutic potential.

bioRxiv · Apr 10, 2023 · PreprintCancer Biology

CD81 partners with CD44 in promoting exosome biogenesis, tumor cluster formation, and lung metastasis in triple negative breast cancer

E. K. Ramos, C.-F. Tsai, N. K. Dashzeveg, Y. Jia, Y. Cao, M. Manu, R. Taftaf, A. D. Hoffmann, L. El-Shennawy, M. A. Gritsenko, V. Adorno-Cruz, E. J. Schuster, D. Scholten, D. Patel, X. Liu, , H. Liu

bioRxiv · Feb 23, 2022Cancer Biology

Circulating ACE2-expressing Exosomes Block SARS-CoV-2 Virus Infection as an Innate Antiviral Mechanism

L. El-Shennawy, A. D. Hoffmann, N. K. Dashzeveg, P. J. Mehl, Z. Yu, V. L. Tokars, V. Nicolaescu, C. Ostiguin, Y. Jia, L. Li, K. Furlong, C. Mao, J. Wysocki, D. Batlle, T. J. Hope, , H. Liu

The paper shows that ACE2-expressing exosomes in plasma block SARS-CoV-2 infection by competing with cellular ACE2, offering a new innate antiviral mechanism.

bioRxiv · Dec 3, 2020Immunology